Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
BMJPublished 6 October 2006Open access
Anders W Jørgensen, Jørgen Hilden, Peter C Gøtzsche
Citations442
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Industry supported reviews of drugs should be read with caution as they were less transparent, had few reservations about methodological limitations of the included trials, and had more favourable conclusions than the corresponding Cochrane reviews.
Abstract
Industry supported reviews of drugs should be read with caution as they were less transparent, had few reservations about methodological limitations of the included trials, and had more favourable conclusions than the corresponding Cochrane reviews.
Keywords
Decision SciencesArts and HumanitiesPharmacology, Toxicology and Pharmaceutics
Cochrane Handbook for Systematic Reviews of Interventions
24,936 Citations2008
BMJAssessing the quality of controlled clinical trials
3,334 Citations2001Peter Jüni, Douglas G Altman +1 more
The concept of study quality and the methods used to assess quality are discussed and the methodology for both the assessment of quality and its incorporation into systematic reviews and meta-analysis is discussed.
BMJPharmaceutical industry sponsorship and research outcome and quality: systematic review
2,163 Citations2003Joel Lexchin, Lisa A Bero +2 more
Investigating whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support found systematic bias favours products which are made by the company funding the research.
Cochrane Database of Systematic ReviewsScreening for breast cancer with mammography
1,867 Citations2013Peter C Gøtzsche, Karsten Juhl Jørgensen
It is found that breast cancer mortality was an unreliable outcome that was biased in favour of screening, mainly because of the risk of differential misclassification of cause of death.
JAMAScope and Impact of Financial Conflicts of Interest in Biomedical Research
1,803 Citations2003Justin E. Bekelman, Yan Li +1 more
Original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research are reviewed to show a statistically significant association between industry sponsorship and pro-industry conclusions.
The LancetRisk of cardiovascular events and rofecoxib: cumulative meta-analysis
838 Citations2004Peter Jüni, Linda Nartey +4 more
The findings indicate that rofecoxib should have been withdrawn several years earlier and the reasons why manufacturer and drug licensing authorities did not continuously monitor and summarise the accumulating evidence need to be clarified.
BMJPublication bias: evidence of delayed publication in a cohort study of clinical research projects
829 Citations1997Jerome M Stern, R. J. Simes
Journal of Clinical EpidemiologyValidation of an index of the quality of review articles
789 Citations1991Andrew D Oxman, Gordon Guyatt
The OQAQ is a valid measure of the quality of research overviews and the primary shortcoming noted was the need for judgement in applying the index.
JAMAAssociation of Funding and Conclusions in Randomized Drug Trials
744 Citations2003Bodil Als‐Nielsen, Wendong Chen +2 more
Conclusions in trials funded by for-profit organizations may be more positive due to biased interpretation of trial results, and readers should carefully evaluate whether conclusions in randomized trials are supported by data.
JAMAMethodology and Reports of Systematic Reviews and Meta-analyses
541 Citations1998Alejandro R. Jadad, Fadi Hammal +5 more
Cochrane reviews appear to have greater methodological rigor and are more frequently updated than systematic reviews or meta-analyses published in paper-based journals.
PubMedGuidelines for reading literature reviews.
495 Citations1988Andrew D Oxman, Gordon Guyatt
New guidelines that will help readers assess the scientific quality of the review are proposed and will allow clinicians to spend their valuable reading time on high-quality material and to judge the validity of an author's conclusions.
The LancetDoes blinding of readers affect the results of meta-analyses?
483 Citations1997Jesse A. Berlin
BMJCochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
442 Citations2006Anders W Jørgensen, Jørgen Hilden +1 more
Industry supported reviews of drugs should be read with caution as they were less transparent, had few reservations about methodological limitations of the included trials, and had more favourable conclusions than the corresponding Cochrane reviews.
BMJSelective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
401 Citations1993Fujian Song, Nick Freemantle +5 more
Routine use of selective serotonin reuptake inhibitors as the first line treatment of depressive illness may greatly increase cost with only questionable benefit, according to meta-analysis of 63 randomised controlled trials.
CirculationCardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
355 Citations2001Marvin A. Konstam, Matthew R. Weir +5 more
This analysis provides no evidence for an excess of CV events for rofecoxib relative to either placebo or the non-naproxen NSAIDs that were studied.
Journal of Clinical EpidemiologyAgreement among reviewers of review articles
283 Citations1991Andrew D Oxman, Gordon Guyatt +5 more
Assessment of the consistency of an index of the scientific quality of research overviews found it was possible to achieve reasonable to excellent agreement for all of the items in the index, including the overall assessment of scientific quality.
Archives of Internal MedicineA Study of Manufacturer-Supported Trials of Nonsteroidal Anti-inflammatory Drugs in the Treatment of Arthritis
277 Citations1994Paula A. Rochon
The manufacturer-associated NSAID is almost always reported as being equal or superior in efficacy and toxicity to the comparison drug, and claims of superiority, especially in regard to side effect profiles, are often not supported by trial data.
Archives of Internal MedicineA study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
275 Citations1994Paula A. Rochon
BMJSystematic reviews and meta-analyses on treatment of asthma: critical evaluation
258 Citations2000Alejandro R. Jadad
Most reviews published in peer reviewed journals or funded by industry have serious methodological flaws that limit their value to guide decisions, but Cochrane reviews are more rigorous and better reported than those published inpeer reviewed journals.
BMJAssessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study
237 Citations2005Lorenzo Moja, Elena Telaro +4 more
Cochrane reviews fared better than systematic reviews published in paper based journals in terms of assessment of methodological quality of primary studies, although they both largely failed to take it into account in the interpretation of results.
Journal of Clinical EpidemiologyMeta-analyses to evaluate analgesic interventions: A systematic qualitative review of their methodology
208 Citations1996Alejandro R. Jadad, Henry J McQuay
Ninety percent of the meta-analyses had methodological flaws that could limit their validity and the main deficiencies were lack of information on methods to retrieve and to assess the validity of primary studies and lack of data on the design of the primary studies.
BMJMeta-analysis: Unresolved issues and future developments
176 Citations1998George Davey Smith, Matthias Egger
In this final article of the series, some of the topics that are likely to feature in future discussions of the appropriate practice and domain of meta-analysis are addressed.
Journal of the Royal Society of MedicineHow objective are systematic reviews? Differences between reviews on complementary medicine
171 Citations2003Klaus Linde, S. N Willich
This analysis shows that, at least in the three areas examined, systematic reviews often differ considerably, and readers should be aware that apparently minor decisions in the review process can have major impact.
BMJQuality of Cochrane reviews: assessment of sample from 1998
159 Citations2001Ole Olsen, Philippa Middleton +6 more
Too often, reviewers' conclusions over-rated the benefits of new interventions and readers of Cochrane reviews should remain cautious, especially regarding conclusions that favour new interventions.
ACC Current Journal ReviewRisk of cardiovascular events and rofecoxib: Cumulative meta-analysis
138 Citations2005Peter Jüni, Linda Nartey +4 more
Journal of the Royal Society of MedicineHow Objective are Systematic Reviews? Differences between Reviews on Complementary Medicine
138 Citations2003Klaus Linde, Stefan N. Willich
This analysis shows that, at least in the three areas examined, systematic reviews often differ considerably, and readers should be aware that apparently minor decisions in the review process can have major impact.
Statistics in MedicineMeta‐analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree
124 Citations1987Thomas C. Chalmers, Jayne Berrier +4 more
The replicate variability of meta-analyses of controlled clinical trials has been assessed as a measure of scientific precision and further work in this area should include multivariate analyses in order to explore possible interactions in the factors accounting for the variability found in replicate meta-Analyses.
Cochrane Database of Systematic ReviewsScreening for breast cancer with mammography
119 Citations2001Ole Olsen, PC G��tzsche
The currently available reliable evidence does not show a survival benefit of mass screening for breast cancer (and the evidence is inconclusive for Breast cancer mortality), and women, clinicians and policy makers should consider these findings carefully when they decide whether or not to attend or support screening programs.
Neuroscience LettersThe role of nitric oxide in chemically- and electrically-induced seizures in mice
101 Citations1996Edmund Przegaliński, L Baran +1 more
Results indicate that nitric oxide (NO) may be regarded as an anticonvulsant substance in relation to seizures induced by NMDA and other excitatory amino acids, but not by other agents, in mice.
BMJStudy of information submitted by drug companies to licensing authorities.
97 Citations1980Elina Hemminki
This study provides support for those who want to see public disclosure of the reports of trials submitted in licensing applications by drug companies to licensing authorities in Finland and Sweden in four different years.
British Journal of PharmacologyThe proconvulsant effect of sildenafil in mice: role of nitric oxide–cGMP pathway
87 Citations2006Kiarash Riazi, Maryam Roshanpour +4 more
Sildenafil induces a proconvulsant effect on clonic seizure threshold that interacts with both exogenously and endogenously released NO and may be linked to activation of NO–cGMP pathway.
BMJThe need for caution in interpreting high quality systematic reviews
85 Citations2001Kevork Hopayian
High quality systematic reviews may overlook important clinical details in the papers reviewed, thereby diminishing their validity, and this shortcoming might be avoided if trials were assessed from a clinician's viewpoint as well as from a reviewer's viewpoint.
DrugsVardenafil
81 Citations2003Gillian M. Keating, Lesley J. Scott
Vardenafil should be considered a first-line treatment option in men with ED who are suitable candidates for oral PDE5 inhibitor therapy, and improvements from baseline in the erectile function domain score of the IIEF and in positive responses to SEP questions were significantly greater with vardenafIL 10 or 20mg than with placebo.
European UrologyThe Efficacy and Safety of Flexible-Dose Vardenafil (Levitra®) in a Broad Population of European Men
81 Citations2004Dimitrios Hatzichristou, Francesco Montorsi +4 more
In this flexible dose study, vardenafil was well-tolerated, and produced clinically relevant improvements in erectile function in men with ED.
The LancetAdult night terrors and paroxetine
78 Citations1997DJ Nutt, SJ Wilson +3 more
It is suggested that the terror-suppressing action of paroxetine is a direct effect of its ability to increase 5hydroxytryptamine concentrations in the brainstem by blocking reuptake, and may be as effective as benzodiazepines, although formal comparison is necessary.
BMJDrug points: Tonic-clonic seizures in patients taking sildenafil
60 Citations2002Royi Gilad
Sildenafil citrate (Viagra) is a specific phosphodiesterase type V inhibitor with a selective inhibitory effect on cyclic guanosine monophosphate (cGMP) responsible for its main clinical effect—relaxation of the smooth muscle in the corpus cavernosum.
American Journal of EpidemiologyVariability in Meta-analytic Results Concerning the Value of Cholesterol Reduction in Coronary Heart Disease: A Meta-Meta-Analysis
55 Citations1999David A. Katerndahl, W. Ross Lawler
Although "supportiveness" of the value of cholesterol reduction was associated with inclusion/exclusion criteria and publication variables, the primary outcome variable related to supportiveness was the statistical significance of the odds ratios for cardiovascular mortality.
JAMAAllocation Concealment in Clinical Trials
47 Citations2002Kenneth F. Schulz, Douglas G. Altman +1 more
Journal of Clinical EpidemiologyMeta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit
26 Citations1992Peter C Gøtzsche
It is concluded that the benefit of second-line drugs is uncertain and no evidence of a worthwhile effect on radiological changes was found.
Revue NeurologiqueCrise d’épilepsie et vardenafil
16 Citations2006Salam Koussa, Samia Chahine +2 more
Des etudes ulterieures pourront elucider l’association entre la famille des inhibiteurs de the phosphodiesterase et le risque de survenue de crises d’epilepsie.
Survey of AnesthesiologyStress Ulcer Prophylaxis in Critically Ill Patients Resolving Discordant Meta-Analyses
10 Citations1996Fadi Hammal, Brenda Reeve +5 more
There is strong evidence of reduced clinically important gastrointestinal bleeding with histamine2-receptor antagonists and sucralfate is as effective in reducing bleeding as gastric pH-altering drugs and is associated with lower rates of pneumonia and mortality.